Example: confidence
NEW ZEALAND DATA SHEET - Medsafe
1 . NEW ZEALAND DATA SHEET . 1. PRODUCT NAME SYNFLORIX pneumococcal polysaccharide conjugate vaccine, 10 valent adsorbed. Suspension for injection.
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Don’t Be Guilty of These Preventable Errors in …
www.immunize.orgDon’t Be Guilty of These . Preventable. Errors in Vaccine Administration (continued) page 3 of 4. error: Giving two doses of live injectable or nasally
Medical Management of Vaccine Reactions in …
immunize.orgMedical Management of Vaccine Reactions in Children and Teens (continued) page 3 of 3 1–6 months 9–19 lb 4–8.5 kg 0.05 mL (or mg) off label 7–36 months 20–32 lb 9–14.5 kg 0.1 mL (or mg) off label
New Zealand Data Sheet - Medsafe
www.medsafe.govt.nzTYPHIM VI DATA SHEET Page 1 of 7 typ-ccdsv9-piv1-29feb16 New Zealand Data Sheet TYPHIM Vi™ Salmonella typhi Vi polysaccharide vaccine DESCRIPTION
VACCINES FOR CHILDREN PROGRAM PROVIDER …
www.vdh.virginia.govPin: _____ 3 PROVIDER AGREEMENT To receive publicly funded vaccines at no cost, I agree to the following conditions, on behalf of myself and all the
IMMUNIZATION QUALIFICATION TRAINING …
static.e-publishing.af.milQTP 4N0X1-12 . 24 October 2014 . IMMUNIZATION . QUALIFICATION TRAINING PACKAGE . Enlisted Air Force Allergy & Immunization Consultant . Air Force Medical Support Agency (AFMSA)
Documenting Shots - health.state.mn.us
www.health.state.mn.usThis section is filled with tips and tools to make documenting shots a more accurate, less complicated task. Overview of this section: Best Practices Checklist: Documenting Shots
2018 Combined Recommended Immunization …
www.cdc.govFigure 2. Recommended immunization schedule for adults aged 19 years or older by medical condition and other indications, United States, 2018